Is There a Big Opportunity for Amarin Investors?

Investor interest in biopharma company Amarin  (Nasdaq: AMRN  )  mounted this summer as the company gained approval from the Food and Drug Administration for its triglyceride-lowering drug, Vascepa. In an effort to help investors examine both the bull and bear cases for this stock, we've put together a brand new premium research report on Amarin that examines the company's market opportunity, biggest threats, and reasons to both buy and sell today.

In the following video, Austin Smith talks with health care analyst Max Macaluso about why this drug has garnered so much attention, what Vascepa actually does, and the competition that Amarin could soon face once this new medication reaches patients.

The biotech space can make or break investors overnight, and while Amarin might not disappear into thin air, the success of Vascepa is key to the company's future success or failure. The company has huge potential, but don't invest a dollar before reading everything you need to know about Amarin. You can start now with top analyst Max Macaluso's premium research report. Click here now to keep reading.

Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2109734, ~/Articles/ArticleHandler.aspx, 3/31/2015 7:51:18 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...